Evidence map›Paper›PMID 33507674›Full record

ReviewAsian Pacific journal of cancer prevention : APJCP2021

Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions.

Pedram Fadavi, Mohammad Houshyari, Amir Shahram Yousefi Kashi, Alireza Mosavi Jarrahi, Farnaz Roshanmehr, Mohammad Ali Broomand, Saleh Sandoughdaran, Farzad Taghizadeh-Hesary

Abstract readReview
In one paragraph

Review in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Smile InHealthcare (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Impact of COVID-19 on Cancer.Infection and drug resistance · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pedram FadaviDepartment of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7491-2561
Mohammad HoushyariDepartment of Clinical Oncology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amir Shahram Yousefi KashiDepartment of Clinical Oncology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Alireza Mosavi JarrahiCancer Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farnaz RoshanmehrFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Mohammad Ali BroomandDepartment of Clinical Oncology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Saleh SandoughdaranShohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad Taghizadeh-HesaryDepartment of Clinical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6195-2203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As of late 2019, the outbreak of novel coronavirus disease (COVID-19) -that started in China- has rapidly afflicted all over the world. The COVID-19 pandemic has challenged health-care facilities to provide optimal care. In this context, cancer care requires special attention because of its peculiar status by including patients who are commonly immunocompromised and treatments that are often highly toxic. In this review article, we have classified the main impacts of the COVID-19 pandemic on oncology practices -followed by their solutions- into ten categories, including impacts on (1) health care providers, (2) medical equipment, (3) access to medications, (4) treatment approaches, (5) patients' referral, (6) patients' accommodation, (7) patients' psychological health, (8) cancer research, (9) tumor board meetings, and (10) economic income of cancer centers. The effective identification and management of all these challenges will improve the standards of cancer care over the viral pandemic and can be a practical paradigm for possible future crises.<br />.

Indexed as

COVID-19HumansMedical OncologyNeoplasmscancer careCOVID-19Pandemic

Identifiers

PMID33507674
PMCPMC8184167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.